Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Shailja V. Parikh"'
Autor:
Shailja V Parikh, Ellen C Keeley
Publikováno v:
Vascular Health and Risk Management, Vol 2009, Iss default, Pp 677-691 (2009)
Shailja V Parikh1, Ellen C Keeley21Departments of Internal Medicine, Divisions of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, 2University of Virginia, Charlottesville, Virginia, USAAbstract: The wide variety of anticoa
Externí odkaz:
https://doaj.org/article/fb56110487154686b36e28a2d1beeefb
Autor:
DaJuanicia N Simon, Jonathan R. Enriquez, Laine Thomas, James A. de Lemos, John A. Spertus, Sandeep R Das, Paul S. Chan, Shailja V. Parikh, Tracy Y. Wang
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 8:576-585
Background— In 2009, national legislation promoted wide-spread adoption of electronic health records (EHRs) across US hospitals; however, the association of EHR use with quality of care and outcomes after acute myocardial infarction (AMI) remains u
Publikováno v:
Cureus
Streptococcus agalactiae (S.agalactiae) is known to cause invasive infections in pregnant women, newborns, and immunosuppressed patients. It is an uncommon but life-threatening case of infective endocarditis in middle-aged otherwise healthy adults. W
Publikováno v:
Cureus
Cardiac metastasis is much more common than primary cardiac tumors. Lung cancer is one of the most common primary malignancies to metastasize to the heart. It is not common for metastasis in the heart to present as a cavitary mass. To our knowledge,
Autor:
Stephan Achenbach, Krishna G. Aragam, Suzanne V. Arnold, Magnus Bäck, Michael J. Blaha, Stefan Blankenberg, Roger S. Blumenthal, Paolo G. Camici, Mina K. Chung, Joaquin E. Cigarroa, Filippo Crea, Karina W. Davidson, Alban De Schutter, Marcelo F. Di Carli, Pamela S. Douglas, Gregory Ducrocq, Connor A. Emdin, Obi Emeruwa, Jonathan R. Enriquez, William F. Fearon, Christopher B. Fordyce, Thomas A. Gaziano, Bernard Gersh, Gitsios Gitsioudis, Yuanlin Guo, Rory Hachamovitch, Göran K. Hansson, Kristopher Heinzman, Timothy D. Henry, Ayman A. Hussein, Jesper K. Jensen, E. Marc Jolicoeur, Sekar Kathiresan, Rajdeep S. Khattar, Amit V. Khera, Mikhail Kosiborod, Lawrence Kwon, Carl J. Lavie, Matthew Lawlor, Steven P. Marso, Seth S. Martin, Nikolaus Marx, Puja K. Mehta, C. Noel Bairey Merz, Erin D. Michos, Richard V. Milani, Christopher J. O’Donnell, Lionel Opie, Shailja V. Parikh, Eva Prescott, Sebastian Reith, Ornella E. Rimoldi, Jennifer G. Robinson, George Rodgers, Anand Rohatgi, Clive Rosendorff, Sheila Sahni, Daniel Sedehi, Roxy Senior, Philippe Gabriel Steg, Lauren Wasson, Karol E. Watson, Janet Wei, Peter W.F. Wilson, Tanja Zeller
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b968c2a318a0da0d374f7bbec3876541
https://doi.org/10.1016/b978-0-323-42880-4.01002-5
https://doi.org/10.1016/b978-0-323-42880-4.01002-5
Autor:
Suresh Mulukutla, Oscar C. Marroquin, J. Dawn Abbott, Michael Luna, Faith Selzer, Shailja V. Parikh, Elizabeth M. Holper
Publikováno v:
Catheterization and Cardiovascular Interventions. 83:192-200
Objectives Examine 1-year outcomes of patients with small coronary arteries in the National Heart, Lung, and Blood Institute Dynamic Registry (NHLBI) undergoing drug-eluting stent (DES) vs. bare-metal stent (BMS) placement. Background While randomize
Autor:
John A. Spertus, Sandeep R Das, Matthew T. Roe, Elizabeth M. Holper, S. Andrew Peng, Anand Rohatgi, Shailja V. Parikh, James A. de Lemos, Jonathan R. Enriquez
Publikováno v:
American Heart Journal. 165:43-49
Although chronic lung disease (CLD) is common among patients with myocardial infarction (MI), little is known about the influence of CLD on patient management and outcomes following MI.Using the National Cardiovascular Data Registry's ACTION Registry
Autor:
Elizabeth M. Holper, Shailja V. Parikh, Faith Selzer, Vankeepuram S. Srinivas, Jonathan R. Enriquez, Suresh Mulukutla, Oscar C. Marroquin, Alice K. Jacobs
Publikováno v:
Chest. 140:604-610
Background Previous studies have demonstrated that patients with COPD are at higher risk for death after percutaneous coronary intervention (PCI), but other clinical outcomes and possible associations with adverse events have not been described. Meth
Autor:
Subhash Banerjee, J. Dawn Abbott, Srihari S. Naidu, Alice K. Jacobs, David P. Faxon, Shoaib Saya, Faith Selzer, Elizabeth M. Holper, Punag Divanji, Robert L. Wilensky, Shailja V. Parikh
Publikováno v:
The American Journal of Cardiology. 107:959-964
Patients with peripheral arterial disease (PAD) undergoing percutaneous coronary intervention (PCI) are at high risk for adverse cardiovascular events. Trends over time in outcomes with advances in PCI and medical therapy are unknown. We evaluated 86